期刊文献+

聚酰胺—胺树枝状高分子/喜树碱复合物的制备及体外释放研究 被引量:2

Preparation and in vitro Release of Camptothecin Complexation with Polyamidoamine
下载PDF
导出
摘要 利用聚酰胺—胺树枝状高分子与喜树碱的静电复合作用进行复合,以水为溶剂,第四、五代聚酰胺—胺树枝状高分子为载体采用搅拌法进行复合,探讨其作为抗肿瘤药物载体的可能性.应用紫外分光光度法(UV)测定复合量,采用高效液相色谱法(HPLC)测定其在PBS中的释放特性.喜树碱在聚酰胺—胺树枝状高分子水溶液中内酯环开环,溶解度增大,在PBS中并无明显的缓释效果.结果表明聚酰胺—胺树枝状高分子不宜作为具内酯环,遇碱不稳定药物的载体. To investigate polyamidoamine (PAMAM) as a potential drug delivery carrier for camptotheein,complexes of the fourth and fifth generation PAMAM/Camptotheein were pre- pared in water by stirring method. The amounts of drug loading were determined by UV,and the release profile by I-IPLC in phosphate buffer solutions. The solubility of Camptothecin enhanced in PAMAM solutions and there were no obvious sustained release effects in PBS. PAMAM could not be used as carriers of unstable drug in weak base condition and hydrophilic drug.
出处 《南华大学学报(自然科学版)》 2011年第2期79-83,共5页 Journal of University of South China:Science and Technology
基金 湖南省教育厅基金资助项目(10C1179) 南华大学博士启动基金资助项目(2010XQD37)
关键词 聚酰胺-胺 喜树碱 复合物 体外释放 polyamidoamine Camptothecin complex in vitro release
  • 相关文献

参考文献10

  • 1Gillies E R, Frechet J M J. Dendrimers and dendritic polymers in drug delivery [ J ]. Drug Discovery Today,2005, 10:35-43.
  • 2Li Qing-Yong, Zu Yuan-Gang, Shi Rong-Zhen, et al. Review Camptothecin : current perspectives [ J ]. Current Medicinal Chemistry, 2006,13 ( 17 ) :2021-2039.
  • 3Joseph F Piaaolato, Leonard B Saltz. The camptothecin [J]. Lancet,2003,361:2235-2242.
  • 4Dennis O Scott, Dilbir S Bindra, Valentino J Stella. Plasma pharmacokinetics of the lactone and carboxylate forms of 20 (S) -camptothecin in anesthetized rats [ J ]. Pharmaceutical Research, 1993,10(10) : 1451-1457.
  • 5Wei Chen, Donald A Tomalia, James L Thomas. Unusual pH-dependent polarity changes in PAMAM dendrimers: evidence for pH-responsive conformational changes [ J ]. Macromolecules ,2000,33:9169-9172.
  • 6Cheng Yiyun, Xu Tongwen. Dendrimers as potential drug eariers. Part I. solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers [ J ]. European Journal of Medicinal Chemistry, 2005,40 : 1182-1192.
  • 7Kolhe P, Misra E, Kanana R M, et al. Drug complexation, in vitro release and cellular entry of dendrimers andhyperbranched polymers [ J ]. International Journal of Pharmaceutics ,2003,259 : 143-160.
  • 8Abhay Singh Chauhan, Narendra kumar Jain, Prakash Vamanro Diwan, et al. Solubility enhancement of indomethacin with poly(amidoamine) dendrimers and targeting the inflammatory regions of arthritic rats [ J ]. Journal of Drug Targeting, 2004,12 ( 9/10 ) : 575-583.
  • 9Man Na, Cheng Yiyun, Xu Tongwen, et al. Dendrimers as potential drug carriers. Part II. Prolonged delivery of ketoprofen by in vitro and in vivo studies [ J ]. European Journal of Medicinal Chemistry,2006,41:670-674.
  • 10Ma Minglu, Cheng Yiyun, Xu Zhenhua, et al. Evaluation of polyamidoamine (PAMAM) dendrimers as drug cartiers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug[J]. European Journal of Medicinal Chemistry,2007,42:93-98.

同被引文献17

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部